Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0001209191-19-021324

Chief Scientific Officer sold 11,485 shares at $4.12 ($47,334)

  • Chief Scientific Officer acquired 11,485 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ettenberg Seth Chief Scientific Officer 2019-03-25 Option exercise +11,485 $0.18 $2,067 11,485 D: show line 1 in the form
Ettenberg Seth Chief Scientific Officer 2019-03-25 Sale −11,485 $4.12 $47,334 0 D: show line 2 in the form
Open-market sales · 11,485 sh · avg $4.12 · $47,334

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ettenberg Seth Chief Scientific Officer 2019-03-25 Grant or award · Stock Option (Right to Buy) +11,485 329,145 D: show line 3 in the form
Loading xslF345X03/doc4.xml…